Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcutis Biotherapeutics (ARQT) Amortizatization of Intangibles (2020 - 2025)

Arcutis Biotherapeutics has reported Amortizatization of Intangibles over the past 6 years, most recently at -$2.0 million for Q4 2025.

  • Quarterly results put Amortizatization of Intangibles at -$2.0 million for Q4 2025, down 283.39% from a year ago — trailing twelve months through Dec 2025 was $2.2 million (down 16.35% YoY), and the annual figure for FY2025 was $2.1 million, down 69.66%.
  • Amortizatization of Intangibles for Q4 2025 was -$2.0 million at Arcutis Biotherapeutics, down from $600000.0 in the prior quarter.
  • Over the last five years, Amortizatization of Intangibles for ARQT hit a ceiling of $6.4 million in Q4 2023 and a floor of -$2.0 million in Q4 2025.
  • Median Amortizatization of Intangibles over the past 5 years was $254500.0 (2021), compared with a mean of $729200.0.
  • Biggest five-year swings in Amortizatization of Intangibles: plummeted 420.83% in 2021 and later skyrocketed 2971.13% in 2025.
  • Arcutis Biotherapeutics' Amortizatization of Intangibles stood at $309000.0 in 2021, then grew by 29.77% to $401000.0 in 2022, then skyrocketed by 1502.49% to $6.4 million in 2023, then tumbled by 82.94% to $1.1 million in 2024, then crashed by 283.39% to -$2.0 million in 2025.
  • The last three reported values for Amortizatization of Intangibles were -$2.0 million (Q4 2025), $600000.0 (Q3 2025), and $600000.0 (Q2 2025) per Business Quant data.